Physician profile
Rajesh Makkenchery
NPI 1104885748
$23,762.28
in general payments reported to CMS, 2019-2025
6 companies · $67.76 in 2025
The $67.76 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.62 · 2022: $283 · 2023: $16K · 2024: $6,899 · 2025: $67.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $19K · Travel and Lodging: $3,200 · Food and Beverage: $1,745 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $18,500.00 |
| Travel and Lodging | $3,199.76 |
| Food and Beverage | $1,745.23 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $23,590.25 | 2022-2024 | Davinci Xi, Da Vinci Surgical System |
| Ethicon US, LLC | $67.76 | 2025 | Echelon Circular, N/A |
| Davol INC. | $36.64 | 2021-2022 | |
| Ambu INC. | $25.85 | 2024 | |
| Merck Sharp & Dohme LLC | $24.15 | 2023 | Bridion |
| Smith+Nephew, INC. | $17.63 | 2024 | Stravix Pl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajesh Makkenchery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.